In a brain tumor model, mice bearing GL261 cell-based glioma were susceptible to the treatment with OX40 mAb and tumor regression was dependent on the participation of both Tc and Tconv cells (Kjaergaard et al., 2000). This evidence concerns the gene TNFRSF4 and brain neoplasm.